$VRTX Q3 2026 results are out.

$VRTX Q3 2026 results are out.

By Nexqual Desk ·

Tickers: $VRTX

$VRTX Q3 2026 results are out.

EPS (GAAP): $2.56

Revenue: $3.44B

Outlook: Full-year 2026 revenue guidance raised to $13.15 billion to $13.25 billion.

Source: Vertex Pharmaceuticals 8-K filed with the SEC.

0 likes

Posted on Nexqual Sonar — the social network for the stock market. Not financial advice.

Data source: Nexqual. Last updated: November 2, 2026 at 23:15 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt